ES8608866A1 - Hot melt antihistamine formulations. - Google Patents

Hot melt antihistamine formulations.

Info

Publication number
ES8608866A1
ES8608866A1 ES546545A ES546545A ES8608866A1 ES 8608866 A1 ES8608866 A1 ES 8608866A1 ES 546545 A ES546545 A ES 546545A ES 546545 A ES546545 A ES 546545A ES 8608866 A1 ES8608866 A1 ES 8608866A1
Authority
ES
Spain
Prior art keywords
hot melt
antihistamine
antihistamine formulations
formulations
hard
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546545A
Other languages
Spanish (es)
Other versions
ES546545A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of ES546545A0 publication Critical patent/ES546545A0/en
Publication of ES8608866A1 publication Critical patent/ES8608866A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Abstract

A hot melt antihistamine composition is described that is suitable for the liquid filling of hard or soft shell capsules and provides a sustained release of the antihistamine.
ES546545A 1984-08-30 1985-08-29 Hot melt antihistamine formulations. Expired ES8608866A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64617984A 1984-08-30 1984-08-30

Publications (2)

Publication Number Publication Date
ES546545A0 ES546545A0 (en) 1986-07-16
ES8608866A1 true ES8608866A1 (en) 1986-07-16

Family

ID=24592083

Family Applications (1)

Application Number Title Priority Date Filing Date
ES546545A Expired ES8608866A1 (en) 1984-08-30 1985-08-29 Hot melt antihistamine formulations.

Country Status (19)

Country Link
EP (1) EP0173293B1 (en)
JP (1) JPH0621068B2 (en)
KR (1) KR920007832B1 (en)
AR (1) AR242341A1 (en)
AT (1) ATE68972T1 (en)
AU (1) AU579177B2 (en)
CA (1) CA1250526A (en)
DE (1) DE3584557D1 (en)
DK (1) DK164642C (en)
ES (1) ES8608866A1 (en)
FI (1) FI87992C (en)
GR (1) GR852078B (en)
HU (1) HU195421B (en)
IE (1) IE58080B1 (en)
IL (1) IL76237A (en)
NZ (1) NZ213248A (en)
PH (1) PH21083A (en)
PT (1) PT81028B (en)
ZA (1) ZA856482B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
AR240018A1 (en) * 1987-10-07 1990-01-31 Merrell Pharma Inc PROCEDURE FOR PREPARING A COMPOSITION THAT INCLUDES DERIVATIVES OF PIPERIDINOALCANOL.
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
DE69027267T2 (en) * 1989-09-07 1996-10-17 Fuji Photo Film Co Ltd Process for processing a silver halide color photographic material
US5270064A (en) * 1991-04-12 1993-12-14 Avian Allure Encapsulated food product with readily removable capsule
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
EP0812195B1 (en) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
PT998272E (en) * 1997-08-26 2003-09-30 Aventis Pharma Inc PHARMACEUTICAL COMPOSITION FOR COMBINATION OF PIPERIDINOALCANOL DECONGESTIONANT
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
FR2838349B1 (en) 2002-04-15 2004-06-25 Laurence Paris LIQUID COMPOSITIONS FOR SUSTAINED RELEASE SOFT CAPSULES AND PROCESS FOR PRODUCING THE SAME
ATE359777T1 (en) * 2002-12-17 2007-05-15 Abbott Gmbh & Co Kg PHARMACEUTICAL COMPOSITION CONTAINING FENOFIBRATIC ACID AND PHYSIOLOGICALLY TOLERABLE SALTS AND DERIVATIVES THEREOF
EP1829541A1 (en) * 2002-12-17 2007-09-05 Abbott GmbH & Co. KG Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
EP2042165A1 (en) * 2007-09-28 2009-04-01 Swiss Caps Rechte und Lizenzen AG Hot-melt filled soft capsules
FR2999937B1 (en) * 2012-12-21 2015-01-09 Sanofi Sa HIGH-FEXOFENADINE SOLID UNIT AND PROCESS FOR PREPARING THE SAME
US20170119680A1 (en) 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3139383A (en) * 1961-06-26 1964-06-30 Norton Co Encapsulated time release pellets and method for encapsulating the same
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
GB2118040A (en) * 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
DE3237814A1 (en) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. WATER-FREE EMULSIONS AND USE THEREOF

Also Published As

Publication number Publication date
PT81028A (en) 1985-09-01
ATE68972T1 (en) 1991-11-15
EP0173293B1 (en) 1991-10-30
ES546545A0 (en) 1986-07-16
AR242341A1 (en) 1993-03-31
AU4669285A (en) 1986-03-06
DK384985D0 (en) 1985-08-23
PT81028B (en) 1987-09-18
HU195421B (en) 1988-05-30
FI87992B (en) 1992-12-15
DK164642B (en) 1992-07-27
ZA856482B (en) 1986-05-28
CA1250526A (en) 1989-02-28
FI853275A0 (en) 1985-08-27
EP0173293A3 (en) 1987-07-01
JPS6160613A (en) 1986-03-28
DK164642C (en) 1992-12-14
GR852078B (en) 1985-12-30
DE3584557D1 (en) 1991-12-05
DK384985A (en) 1986-03-01
AU579177B2 (en) 1988-11-17
JPH0621068B2 (en) 1994-03-23
IL76237A0 (en) 1986-01-31
EP0173293A2 (en) 1986-03-05
HUT38248A (en) 1986-05-28
KR870001830A (en) 1987-03-28
IL76237A (en) 1989-01-31
IE58080B1 (en) 1993-06-30
KR920007832B1 (en) 1992-09-18
PH21083A (en) 1987-07-16
NZ213248A (en) 1988-07-28
IE852134L (en) 1986-02-28
FI87992C (en) 1993-03-25
FI853275L (en) 1986-03-01

Similar Documents

Publication Publication Date Title
ES8608866A1 (en) Hot melt antihistamine formulations.
DE3474511D1 (en) Pharmaceutical composition containing urokinase
KR960009650B1 (en) Sustained release pharmaceutical composition of diltiazem
EP0172014A3 (en) Formulations of ibuprofen
ZA821222B (en) Composition for lining the walls of reactors and the like
GB8502974D0 (en) Sustained release of active substance
GB2120937B (en) Implant for sustained release of pharmaceutical agents
IL75490A0 (en) Controlled release pharmaceutical compositions containing solid dispersions of active agent
PH23528A (en) Sustained release capsule or tablet formulation
DE3568680D1 (en) Reproduction of coloured images
JPS5731624A (en) Formation of rubidium 82 and dissolution releasing agent
GB2164643B (en) Tricyclic dihydropyridazinones and pharmaceutical compositions containing them
JPS56103110A (en) Sustained release medicinal composition
GB2098867B (en) Sustained release pharmaceutical composition
EP0201537A4 (en) Novel use of anti-nausea and anti-emetic pharmazeutical agents.
ZA882963B (en) New ophtalmological composition of matter
JPS55138457A (en) Fusible soft capsule
AU1875183A (en) Pharmaceutical composition of clotrimazole
JPS57206615A (en) Medicinal composition containing guanfasin
IL59137A (en) Soft gelatin capsules for oral use
DE3276787D1 (en) Protective composition for users of cyanocrylate adhesives
EP0084190A3 (en) Medicinal composition, package and method of making the composition
IL74459A (en) Controlled release pharmaceutical compositions containing bromocriptine
JPS52110818A (en) Stable composition containing water-soluble medicine
JPS5766755A (en) Manufacture of hard capsule tablet

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060503